Orion Oyj (Orion Oyj) Asset Impairment Charge : $0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Orion Oyj Asset Impairment Charge?

Orion Oyj's Asset Impairment Charge for the three months ended in Mar. 2024 was $0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.

Orion Oyj Asset Impairment Charge Historical Data

The historical data trend for Orion Oyj's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Asset Impairment Charge Chart

Orion Oyj Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Orion Oyj Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Orion Oyj Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Orion Oyj Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Oyj (Orion Oyj) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (OTCPK:ORINY) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

1ORNBV:Italy ORNBVh:UK 0M2O:UK ORNBV:Finland ORNAV:Finland OFK:Germany

Address

Orionintie 1, P.O. Box 65, Espoo, FIN, FI-02200

Website

https://www.orion.fi

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.

Orion Oyj (Orion Oyj) Headlines

From GuruFocus

Q4 2023 Orion Oyj Earnings Call Transcript

By GuruFocus Research • 02-14-2024